Predicting survival with reperfusion arrhythmias during primary percutaneous coronary intervention for acute

Reuben Ilia1, Doron Zahger, Carlos Cafri

  • 1Department of Cardiology, Soroka University Hospital and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. iliar@bgu.ac.il

Insights

Reperfusion arrhythmia (RA) after primary percutaneous coronary intervention for ST-elevation myocardial infarction is linked to better patient characteristics and improved survival. This finding suggests RA may indicate a favorable prognosis in STEMI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • The prognostic significance of reperfusion arrhythmia (RA) following successful recanalization in ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PPCI) remains debated.
  • Understanding this association is crucial for risk stratification and treatment optimization.

Purpose of the Study:

  • This study aimed to investigate the relationship between reperfusion arrhythmia and both short-term and long-term survival outcomes in STEMI patients undergoing PPCI.

Main Methods:

  • A prospective registry of consecutive STEMI patients treated with PPCI was utilized.
  • Patients with suboptimal epicardial flow (TIMI flow grade < 3) post-procedure were excluded from the analysis.

Main Results:

  • Reperfusion arrhythmia (RA) was observed in 29% of the 688 STEMI patients.
  • Patients with RA exhibited lower rates of diabetes and hypertension, and a shorter pain-to-balloon time compared to those without RA.
  • Thirty-day mortality was significantly lower in patients with RA (3.7% vs. 8.3%).
  • After adjusting for covariates, RA was associated with a 54% reduction in mortality risk during a median follow-up of 466 days (HR 0.46, 95% CI 0.23-0.92).

Conclusions:

  • The occurrence of RA immediately after PPCI for acute STEMI is associated with favorable clinical characteristics.
  • RA identifies a subgroup of STEMI patients with a particularly favorable short- and long-term prognosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...